This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Florida Research Foundation Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Sean M Crosson: Innovator in Weight Loss Solutions
Introduction
Sean M Crosson is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of weight loss and diabetes treatment through his innovative research and patents. His work focuses on the development of methods and compositions that utilize peptides to promote weight loss and alter taste sensitivity.
Latest Patents
Sean M Crosson holds a patent for "Satiation peptides for weight loss and altered taste sensitivity." This patent provides methods and compositions for AAV-mediated delivery of PYY and Glucagon-like Peptide 1 or an analog thereof, such as Exendin-4, to a subject. The application outlines various embodiments, including topical delivery methods for Ex-4 and PYY peptides. These innovations are designed to promote weight loss and alter lipid taste sensitivity, as well as to assist in the treatment of diabetes.
Career Highlights
Sean is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance his research in the field of health and nutrition. His work has garnered attention for its potential impact on obesity and diabetes management.
Collaborations
Throughout his career, Sean has collaborated with esteemed colleagues, including Sergei Zolotukhin and Cedrick Shawn Dotson. These partnerships have contributed to the development and refinement of his innovative approaches to weight loss and taste sensitivity.
Conclusion
Sean M Crosson is a pioneering inventor whose work in satiation peptides offers promising solutions for weight loss and diabetes treatment. His contributions to the field highlight the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
